Purification and biochemical characterization of lactoperoxidase from Jersey bovine milk and kefir: inhibition and molecular modeling

2025

Closed access Metadata (CSL-JSON)
DOI 10.1080/10826068.2025.2578272
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

This study aimed to purify and biochemically characterize lactoperoxidase (LPO) enzymes obtained from Jersey bovine milk and starter culture fermented kefir, and to investigate the inhibitory effects of sulfanilamide and sulfaguanidine. LPO enzymes were purified using ammonium sulfate precipitation followed by hydrophobic interaction chromatography (sepharose 4B-L-tyrosine-1-naphthylamine); milk LPO reached 220.8 ± 5.41 fold purification with 24.08 ± 0.30% yield, whereas kefir LPO achieved 399.2 ± 7.51 fold with 39.91 ± 0.45% yield. SDS-PAGE analysis revealed a single band with an approximate molecular weight of 80 kDa for both enzymes. Kinetic studies showed that kefir LPO exhibited a lower Km (0.088 ± 0.016 mM) and a higher apparent Vmax (294 ± 0.9 EU·mL−1) than milk LPO (Km 0.166 ± 0.071 mM; Vmax 238 ± 0.7 EU·mL−1). Inhibition assays demonstrated competitive behavior for both inhibitors; by Ki, sulfaguanidine was more potent than sulfanilamide (milk: 5.79 ± 0.78 vs 12.2 ± 1.23 μM; kefir: 5.08 ± 0.82 vs 25 ± 1.18 μM). Molecular docking reproduced the crystallographic pose (redocking RMSD 0.99 Å), and molecular dynamics (MD) simulations indicated more persistent binding of sulfanilamide at the active site.